Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma

Treatment for advanced adrenocortical carcinoma (ACC) consists of mitotane alone or combined with etoposide, doxorubicin, and cisplatin (EDP). Although both therapies are widely used, markers of response are still lacking. Since inflammation-based scores have been proposed as prognostic factors in A...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangone, Alessandra, Altieri, Barbara, Detomas, Mario, Prete, Alessandro, Abbas, Haider, Asia, Miriam, Elhassan, Yasir S, Mantovani, Giovanna, Ronchi, Cristina L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083578/
https://www.ncbi.nlm.nih.gov/pubmed/36715606
http://dx.doi.org/10.1530/ERC-22-0372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083578/
https://www.ncbi.nlm.nih.gov/pubmed/36715606
http://dx.doi.org/10.1530/ERC-22-0372

Ejemplares similares